FDA approved an at-home nasal spray flu vaccine
AstraZeneca’s FluMist approval for self-administration could increase flu vaccine uptake: GlobalData
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, and this rate is only expected to increase marginally over the coming years.
FDA approves first flu vaccine that can be self-administered at home
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.
Nasal spray flu vaccine approved for home use: Here’s what to know
The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company and Covid vaccine-maker AstraZeneca, was announced last week and can be used by adults aged 49 and under.
With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on AstraZeneca's influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17.
First self-administered, at-home flu vaccine receives FDA approval
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first self-administered flu vaccine that can be taken right at home.
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
AstraZeneca’s FluMist approval for self-administration could increase flu vaccine uptake
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, and this rate is only expected to increase marginally over the coming years.
FDA Approves FluMist Nasal Flu Vaccine for Home Use: How It Compares to the Regular Flu Shot
Getting your yearly flu vaccine is essential to prevent illness during cold and flu season. But if you’re not a fan of needles, the experience isn’t exactly enjoyable. Enter: FluMist, the newly FDA-approved at-home nasal flu vaccine.
US’ first self-administered flu vaccine could increase accessibility and uptake
The US Food and Drug Administration (FDA) has approved the first self-administered seasonal influenza vaccine - AstraZeneca’s FluMist. FluMist has been available in the US since 2003, but beginning next year,
Axios on MSN4d
At-home nasal spray flu vaccine coming next year
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...
At-home flu vaccine authorized by FDA
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
An At-Home Nasal Flu Vaccine Is Coming Next Year
I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...
News Nation on MSN4d
FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
KSL7d
FDA approves flu vaccine that can be self-administered at home
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...